Odyssey Therapeutics, Inc. (NASDAQ:ODTX – Get Free Report) major shareholder Tpg Gp A, Llc acquired 1,388,889 shares of the company’s stock in a transaction that occurred on Monday, May 11th. The stock was acquired at an average price of $18.00 per share, with a total value of $25,000,002.00. Following the acquisition, the insider directly owned 3,690,146 shares of the company’s stock, valued at approximately $66,422,628. This represents a 60.35% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through this link. Large shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.
Odyssey Therapeutics Price Performance
Shares of ODTX stock opened at $17.62 on Friday. Odyssey Therapeutics, Inc. has a fifty-two week low of $15.35 and a fifty-two week high of $20.30.
Wall Street Analysts Forecast Growth
Separately, Wall Street Zen upgraded shares of Odyssey Therapeutics to a “hold” rating in a research note on Saturday.
Further Reading
- Five stocks we like better than Odyssey Therapeutics
- Viking Sails to All-Time Highs—Fundamentals Signal More to Come
- Datavalut Gains Traction: 5 Reasons to Sell Now
- TMC Stock: Why This Pre-Revenue Miner Is Worth Watching
- The Power Grid Is Dying—Is It Time to Buy Its Replacement?
Receive News & Ratings for Odyssey Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Odyssey Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
